HVM
REGN icon

Harvest Volatility Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Harvest Volatility Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,326
Closed -$2.39M – 107
2023
Q2 		$2.39M Sell
3,326
-540
-14% -$416K 0.48% 36
2023
Q1 		$3.14M Sell
3,866
-663
-15% -$500K 0.63% 32
2022
Q4 		$3.27M Sell
4,529
-1,160
-20% -$856K 0.66% 33
2022
Q3 		$3.94M Sell
5,689
-126
-2% -$79.3K 0.68% 31
2022
Q2 		$3.44M Sell
5,815
-676
-10% -$439K 0.55% 37
2022
Q1 		$4.53M Buy
6,491
+6,485
+108,083% +$4.1M 0.51% 37
2021
Q4 		$4.06K Sell
6
-4,842
-100% -$2.98M ﹤0.01% 55
2021
Q3 		$2.93M Buy
4,848
+1,854
+62% +$1.15M 0.14% 46
2021
Q2 		$1.67M Buy
2,994
+712
+31% +$361K 0.14% 54
2021
Q1 		$1.08M Buy
2,282
+874
+62% +$426K 0.1% 58
2020
Q4 		$680K Buy
+1,408
New +$760K 0.08% 61

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Harvest Volatility Management's REGN Position: Q3 2023 in Review

Harvest Volatility Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2023, closing a stake of 3,326 shares — an estimated $2.39M sold.

Harvest Volatility Management first reported a position in REGN in Q4 2020 and held it in 11 quarters. The position peaked at $4.53M in Q1 2022. 1,177 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

  • Harvest Volatility Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Harvest Volatility Management sold 3,326 Regeneron Pharmaceuticals shares in Q3 2023, an estimated $2.39M.
  • Harvest Volatility Management first reported a position in Regeneron Pharmaceuticals in Q4 2020 and held it in 11 quarters.
  • Harvest Volatility Management's Regeneron Pharmaceuticals position peaked at $4.53M in Q1 2022.
  • 1,177 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on Harvest Volatility Management's 13F filing for Q3 2023, filed 7 Nov 2023.